Catastrophic antiphospholipid syndrome during pregnancy and puerperium:: maternal and fetal characteristics of 15 cases

被引:63
作者
Gomez-Puerta, Jose A.
Cervera, Ricard
Espinosa, Gerard
Asherson, Ronald A.
Garcia-Carrasco, Mario
da Costa, Izaias P.
Andrade, Danieli C. O.
Borba, Eduardo F.
Makatsaria, Alexander
Bucciarelli, Silvia
Ramos-Casals, Manuel
Font, Josep
机构
[1] Hosp Clin Barcelona, Inst Clin Med & Dermatol, Dept Autoimmune Dis, Serv Malalties Autoimmunes, Barcelona 08036, Catalonia, Spain
[2] Univ Witwatersrand, Sch Pathol, Div Immunol, ZA-2050 Wits, South Africa
[3] Benemetria Univ Autonoma Puebla, Fac Med, Dept Reumatol IMSS Puebla, Unidad Enfermedades Autoimmunes, Puebla, Mexico
[4] Univ Fed Mato Grosso do Sul, Fac Med, Dept Clin Med, Campo Grande, Brazil
[5] Univ Sao Paulo, Div Rheumatol, Sao Paulo, Brazil
[6] Moscow Med Acad, Dept Obstet & Gynecol, Moscow, Russia
关键词
D O I
10.1136/ard.2006.061671
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The catastrophic variant of the antiphospholipid syndrome (APS) is a life-threatening form of presentation of this syndrome that can be triggered by several factors. Aim: To describe the characteristics of patients who developed catastrophic APS triggered during pregnancy and puerperium. Methods: A review of the first 255 cases collected in the website-based "CAPS Registry'' was undertaken. Three new and unpublished cases of catastrophic APS developed during pregnancy and puerperium were added. Results: Fifteen cases were identified. The mean (range) age was 27 (17-38) years. Most patients had a previous unsuccessful obstetric history. In 7 of 14 (50%) cases with available medical history, the catastrophic APS appeared during pregnancy, in 6 (43%) during the puerperium and in 1 (7%) after curettage for a fetal death. The main clinical and serological characteristics were similar to those patients with catastrophic APS triggered by other factors, except for a history of a higher prevalence of previous abortions (p, 0.01). Several specific features were found, including the HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome in 8 (53%) patients, placental infarctions in 4 (27%) patients, and pelvic vein thrombosis and myometrium thrombotic microangiopathy in 1 (7%) patient each. Mortality rate was high for the mothers (46%), and for the babies (54%). Conclusions: It is important to consider the possibility of the development of catastrophic APS in those patients with signs of HELLP syndrome and multiorgan failure during pregnancy or puerperium, especially in those patients with previous history of abortions and/ or thrombosis.
引用
收藏
页码:740 / 746
页数:7
相关论文
共 28 条
[21]  
Ortiz P, 2003, NEFROLOGIA, V23, P459
[22]   Thrombotic thrombocytopenic purpura and pregnancy: Report of four cases and literature review [J].
Shamseddine, A ;
Chehal, A ;
Usta, I ;
Salem, Z ;
El-Saghir, N ;
Taher, A .
JOURNAL OF CLINICAL APHERESIS, 2004, 19 (01) :5-10
[23]   MATERNAL-PERINATAL OUTCOME ASSOCIATED WITH THE SYNDROME OF HEMOLYSIS, ELEVATED LIVER-ENZYMES, AND LOW PLATELETS IN SEVERE PREECLAMPSIA-ECLAMPSIA [J].
SIBAI, BM ;
TASLIMI, MM ;
ELNAZER, A ;
AMON, E ;
MABIE, BC ;
RYAN, GM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (03) :501-509
[24]  
Sinha J, 2002, J RHEUMATOL, V29, P195
[25]   The HELLP syndrome in the antiphospholipid syndrome:: Retrospective study of 16 cases in 15 women [J].
Thuong, DLT ;
Tieulié, N ;
Costedoat, N ;
Andreu, MR ;
Wechsler, B ;
Vauthier-Brouzes, D ;
Aumaître, O ;
Piette, JC .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :273-278
[26]   Venous thromboembolism during pregnancy [J].
Toglia, MR ;
Weg, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :108-114
[27]   Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-Syndrome [J].
von Tempelhoff, GF ;
Heilmann, L ;
Spanuth, E ;
Kunzmann, E ;
Hommel, G .
THROMBOSIS RESEARCH, 2000, 100 (04) :363-365
[28]  
Wislowska M, 1999, CLIN EXP RHEUMATOL, V17, P261